As filed with the Securities and Exchange Commission on May 1, 2009
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
LIFE TECHNOLOGIES CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware | 5791 Van Allen Way Carlsbad, California 92008 |
33-0373077 | ||
(State of Incorporation) | (Address of Principal Executive Offices) | (I.R.S. Employer Identification No.) |
Invitrogen Corporation 1998 Employee Stock Purchase Plan (as Amended Through April 30, 2009)
(Full Title of the Plan)
John A. Cottingham, Esq.
Chief Legal Officer and Secretary
Life Technologies Corporation
5791 Van Allen Way
Carlsbad, California 92008
(760) 603-7200
(Name, address, and telephone number of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer x | Accelerated filer ¨ | Non-accelerated filer ¨ | Smaller reporting company ¨ | |||
(Do not check if a smaller reporting company) |
CALCULATION OF REGISTRATION FEE
Title of securities to be registered |
Amount to be registered (1) |
Proposed maximum offering price per share (2) |
Proposed maximum aggregate offering price |
Amount of registration Fee | ||||
Shares of Common Stock, par value $0.01 per share |
4,662,273 | $25.91 | $120,809,984 | $6,741.20 | ||||
(1) | The securities to be registered include 662,273 previously authorized shares, and 4,000,000 additional shares approved by the stockholders on April 30, 2009, of common stock, $0.01 par value (Common Stock), of Life Technologies Corporation (the Registrant) issuable pursuant to the Invitrogen Corporation 1998 Employee Stock Purchase Plan (as amended through April 30, 2009) (the Plan). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction. |
(2) | Estimated pursuant to Rule 457 solely for purposes of calculating the registration fee based upon 85% of the average of the high and low prices of the Registrants Common Stock on April 24, 2009, as reported on the NASDAQ GlobalSelect Market. |
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENTS ON FORM S-8
The contents of the Registration Statements on Form S-8 previously filed with respect to the Plan and listed below are incorporated by reference herein.
Form S-8 (SEC File No. 333-74061), Filed March 8, 1999
Form S-8 (SEC File No. 333-36606), Filed May 9, 2000
Form S-8 (SEC File No. 333-112495), Filed September 19, 2000
Form S-8 (SEC File No. 333-112495), Filed February 5, 2004
Form S-8 (SEC File No. 333-115447), Filed May 13, 2004
Item 8. | Exhibits. |
See Exhibit Index.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Carlsbad, State of California, on May 1, 2009.
LIFE TECHNOLOGIES CORPORATION | ||
By: | /s/ David F. Hoffmeister | |
David F. Hoffmeister | ||
Chief Financial Officer |
3
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John A. Cottingham and David Szekeres, or either of them, acting individually and without the other, as his attorney-in-fact, each with full power of substitution, for him in any and all capacities, to sign any and all amendments to this registration statement on Form S-8, including any and all post-effective amendments and amendments thereto, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature |
Title |
Date | ||
/s/ Gregory T. Lucier Gregory T. Lucier |
Chairman and Chief Executive Officer (Principal Executive Officer) | May 1, 2009 | ||
/s/ David F. Hoffmeiser David F. Hoffmeister |
Chief Financial Officer (Principal Financial Officer) | May 1, 2009 | ||
/s/ Kelli A. Richard Kelli A. Richard |
Vice President, Finance (Principal Accounting Officer) | May 1, 2009 | ||
/s/ George F. Adam George F. Adam, Jr. |
Director | May 1, 2009 | ||
/s/ Raymond V. Dittamore Raymond V. Dittamore |
Director | May 1, 2009 | ||
/s/ Donald W. Grimm Donald W. Grimm |
Director | May 1, 2009 | ||
/s/ Balakrishnan S. Iyer Balakrishnan S. Iyer |
Director | May 1, 2009 | ||
/s/ Arnold J. Levine Arnold J. Levine, PH.D |
Director | May 1, 2009 | ||
/s/ William H. Longfield William H. Longfield |
Director | May 1, 2009 | ||
/s/ Bradley G. Lorimer Bradley G. Lorimier |
Director | May 1, 2009 | ||
/s/ Per A. Peterson Per A. Peterson, PH.D. |
Director | May 1, 2009 | ||
/s/ Ronald A. Matricaria Ronald A. Matricaria |
Director | May 1, 2009 | ||
/s/ W. Ann Reynolds W. Ann Reynolds, PH.D. |
Director | May 1, 2009 |
4
/s/ William S. Shanahan William S. Shanahan |
Director | May 1, 2009 | ||
/s/ David C. UPrichard David C. UPrichard, PH.D. |
Director | May 1, 2009 |
5
EXHIBIT INDEX
4.1 | Restated Certificate of Incorporation, as amended (1) | |
4.2 | Third Amended and Restated Bylaws (2) | |
5.1 | Opinion of DLA Piper LLP (US) | |
23.1 | Consent of Counsel (included in Exhibit 5.1) | |
23.2 | Consent of Independent Registered Public Accounting Firm | |
24 | Power of Attorney (included in signature pages to this Registration Statement) | |
99.1 | Invitrogen Corporation 1998 Employee Stock Purchase Plan (as amended through April 30, 2009) (3) |
(1) | Incorporated by reference to Exhibit 3.1 of the Registrants Annual Report on Form 10-K for the year ended December 31, 2008 (SEC File No. 000-25317), as filed on March 2, 2009. |
(2) | Incorporated by reference to Exhibit 3.2 of the Registrants Annual Report on Form 10-K/A for the year ended December 31, 2008 (SEC File No. 000-25317), as filed on March 11, 2009. |
(3) | Incorporated by reference to Appendix A of the Registrants Proxy Statement for the 2009 annual meeting of stockholders on Form DEF14A (SEC File No. 000-25317), as filed on March 20, 2009. |
6